Biotechnology company FortuneRock is set to float on the National Equities Exchange and Quotations in China, giving Jinhua Pharmaceuticals an exit.

The Rocket Internet and Vorwerk-backed meal delivery service would likely be valued at about $1.1bn in the offering, after raising almost $200m in funding.

The Celgene and Sorrento-backed immunotherapy drug developer initially raised $207m when it floated on Nasdaq last week.

Celgene will invest $17m in the immuno-oncology company, also backed by Sorrento, as it floats in the largest biotech initial public offering ever.

The mobile payment company has filed confidentially for an initial public offering that would grant exits to Visa, Citi and Starbucks.

The flat screen television producer, backed by two of its manufacturing partners, is set to go public 13 years after it was founded.

Siemens-backed cancer therapy developer ViewRay has raised $26.7m in equity and gone public through a reverse merger with a shell company.

Metaps, which has grown from an app monetisation platform into a more diversified technology business, is set to go public, giving exits to Intec and MotionBeat.

Jupai, a China-based wealth management and advisory service backed by Sina and E-House, will float on the New York Stock Exchange later today.

Novartis-backed GenSight, which is developing eye disease treatments, raised almost $42m in its only publicly disclosed funding round.